Fulcrum Therapeutics, Inc. FULC
3.65 USD -0.06 -1.62%
At close · Nov 2
3.65 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
- YTD
- -67.73%
- 1 year
- -58.29%
- Open
- 3.72
- Prev close
- 3.71
- Mkt cap
- 278.79M
- Vol
- 1.21M
- Avg vol
- 1.53M
- EPS
- -1.21
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.64
- High
- 3.73
- Forward P/E
- -3.84
- Beta
- 2.23
- Short ratio
- 7.67
- Inst. own
- 89.70%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Jul 31, 2024
- 50-d avg
- 3.58
- 200-d avg
- 6.57
- 1y target
- 5.29
MAX chart
Chart tools
Chart is warming up
The all-time price history for FULC has not been loaded yet. Try again in a moment.
Altman Z-Score
10.41 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B3 / 5 overall
- DCF 4
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 5
P/E -9.6×
P/S 0.0×
P/B 2.1×
P/FCF -11.9×
EV/EBITDA -7.2×
EV/Sales 0.0×
FCF Yield -8.4%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
ROE -21.5%
ROIC -23.8%
ROA -20.4%
Revenue -100.0%
Operating Income -287.1%
EPS (diluted) -637.5%
Free Cash Flow -2319.0%
Current Ratio 27.4×
Quick Ratio 27.4×
Debt / Equity 0.0×
Net Debt / EBITDA 2.6×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31